Lenacapavir: A Novel, Potent, and Selective First-in-Class Inhibitor of HIV-1 Capsid Function Exhibits Optimal Pharmacokinetic Properties for a Long-Acting Injectable Antiretroviral Agent
雷那卡韦:一种新型、强效、选择性的 HIV-1 衣壳功能抑制剂,具有最佳的长效注射抗逆转录病毒药物药代动力学特性
期刊:Molecular Pharmaceutics
影响因子:3.2
doi:10.1021/acs.molpharmaceut.3c00626
Raju Subramanian, Jennifer Tang, Jim Zheng, Bing Lu, Kelly Wang, Stephen R Yant, George J Stepan, Andrew Mulato, Helen Yu, Scott Schroeder, Naveed Shaik, Renu Singh, Scott Wolckenhauer, Anne Chester, Winston C Tse, Anna Chiu, Martin Rhee, Tomas Cihlar, William Rowe, Bill J Smith